BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21057810)

  • 1. EGFR mutation detection in NSCLC--assessment of diagnostic application and recommendations of the German Panel for Mutation Testing in NSCLC.
    Penzel R; Sers C; Chen Y; Lehmann-Mühlenhoff U; Merkelbach-Bruse S; Jung A; Kirchner T; Büttner R; Kreipe HH; Petersen I; Dietel M; Schirmacher P
    Virchows Arch; 2011 Jan; 458(1):95-8. PubMed ID: 21057810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of the cobas EGFR Mutation Assay in Non-small-cell Lung Cancer Compared With Three Laboratory-developed Tests.
    Nakamura H; Koizumi H; Sakai H; Kimura H; Miyazawa T; Marushima H; Saji H; Takagi M
    Clin Lung Cancer; 2018 Mar; 19(2):170-174. PubMed ID: 29150249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and breakdown of EGFR exon 20 driver mutations in routine NHS lung cancer diagnostic testing.
    Moore DA; Balbi KJ; Poskitt B; Bennett P
    J Clin Pathol; 2022 Mar; 75(3):209-210. PubMed ID: 34168072
    [No Abstract]   [Full Text] [Related]  

  • 4. EGFR Mutational Profiling in Non-Small Cell Lung Cancer: The Clinical Performance of a Sensitive Reverse-Hybridization Assay.
    Kriegshäuser G; Enko D; Novy M; Reitmayr A; Loidl A; Halwachs-Baumann G; Oberkanins C
    Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):388-392. PubMed ID: 27801728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling of circulating tumor DNA in plasma of non-small cell lung cancer patients, monitoring of epidermal growth factor receptor p.T790M mutated allelic fraction using beads, emulsion, amplification, and magnetics companion assay and evaluation in future application in mimicking circulating tumor cells.
    Garcia J; Wozny AS; Geiguer F; Delherme A; Barthelemy D; Merle P; Tissot C; Jones FS; Johnson C; Xing X; Xu Z; Edelstein DL; Brevet M; Souquet PJ; Rodriguez-Lafrasse C; Payen L; Couraud S
    Cancer Med; 2019 Jul; 8(8):3685-3697. PubMed ID: 31112372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High feasibility of liquid-based cytological samples for detection of EGFR mutations in Chinese patients with NSCLC.
    Wu CY; Hou LK; Ren SX; Su B; Chen G
    Asian Pac J Cancer Prev; 2014; 15(18):7885-9. PubMed ID: 25292082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of epidermal growth factor receptor mutations in non-small cell lung cancer tumor specimens from various ways by denaturing high-performance liquid chromatography].
    Chen S; Chen Z; Guo A; Su J; Huang Y; Chen S; Zhang X; Yang X; Yang J; Wu Y
    Zhongguo Fei Ai Za Zhi; 2010 Sep; 13(9):850-5. PubMed ID: 20840812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive detection of EGFR deletion at exon 19 in non-small cell lung cancer by real time diagnostic.
    Sun H; Gan ZC; Gao JJ; Zheng F
    Clin Lab; 2014; 60(9):1517-26. PubMed ID: 25291948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expanding capability and clinical relevance of molecular diagnostic technology to identify and evaluate EGFR mutations in advanced/metastatic NSCLC.
    Shah P; Sands J; Normanno N
    Lung Cancer; 2021 Oct; 160():118-126. PubMed ID: 34500194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR Gene Mutation and Methodological Evaluation in 399 Patients with Non-small Cell Lung Cancer.
    Zheng HY; Wang HB; Shen FJ; Tong YQ; Yao Q; Qiao B; Sun S; Li Y
    Curr Med Sci; 2020 Feb; 40(1):78-84. PubMed ID: 32166668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of EGFR and KRAS mutation status from FNAs and core-needle biopsies of non-small cell lung cancer.
    Lozano MD; Labiano T; Echeveste J; Gurpide A; Martín-Algarra S; Zhang G; Sharma A; Palma JF
    Cancer Cytopathol; 2015 Apr; 123(4):230-6. PubMed ID: 25529460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma-based early screening and monitoring of EGFR mutations in NSCLC patients by a 3-color digital PCR assay.
    Song X; Gong J; Zhang X; Feng X; Huang H; Gao M; Chu L
    Br J Cancer; 2020 Oct; 123(9):1437-1444. PubMed ID: 32782293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of an EGFR mutation in cytological specimens of lung adenocarcinoma.
    Mohar B; Smojver Ježek S; Rajković Molek K; Štemberger C; Kurpis M; Kupanovac Ž; Samaržija M; Jonjić N; Grahovac B
    Cytopathology; 2016 Dec; 27(6):444-451. PubMed ID: 26990359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-validation study for epidermal growth factor receptor and KRAS mutation detection in 74 blinded non-small cell lung carcinoma samples: a total of 5550 exons sequenced by 15 molecular French laboratories (evaluation of the EGFR mutation status for the administration of EGFR-TKIs in non-small cell lung carcinoma [ERMETIC] project--part 1).
    Beau-Faller M; Degeorges A; Rolland E; Mounawar M; Antoine M; Poulot V; Mauguen A; Barbu V; Coulet F; Prétet JL; Bièche I; Blons H; Boyer JC; Buisine MP; de Fraipont F; Lizard S; Olschwang S; Saulnier P; Prunier-Mirebeau D; Richard N; Danel C; Brambilla E; Chouaid C; Zalcman G; Hainaut P; Michiels S; Cadranel J
    J Thorac Oncol; 2011 Jun; 6(6):1006-15. PubMed ID: 21532509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small-cell lung cancers.
    Savic S; Tapia C; Grilli B; Rufle A; Bihl MP; de Vito Barascud A; Herzog M; Terracciano L; Baty F; Bubendorf L
    Br J Cancer; 2008 Jan; 98(1):154-60. PubMed ID: 18087280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus recommendations for optimizing biomarker testing to identify and treat advanced
    Cheema PK; Gomes M; Banerji S; Joubert P; Leighl NB; Melosky B; Sheffield BS; Stockley T; Ionescu DN
    Curr Oncol; 2020 Dec; 27(6):321-329. PubMed ID: 33380864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Epidermal Growth Factor Receptor (EGFR) Gene Mutation in Formalin Fixed Paraffin Embedded Tissue by Polymerase Chain Reaction-Single Strand Conformational Polymorphism (PCR-SSCP) in Non-Small Cell Lung Cancer in the Northeastern Region of Thailand.
    Saiyaros K; Kritpetcharat P; Pairojkul C; Sithithaworn J
    Asian Pac J Cancer Prev; 2019 May; 20(5):1339-1343. PubMed ID: 31127887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies and Progress of EGFR exon 20 Insertion Mutation in Non-small Cell Lung Cancer].
    Zhou W; Zhang W; Han B
    Zhongguo Fei Ai Za Zhi; 2020 Feb; 23(2):118-126. PubMed ID: 32093456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved EGFR mutation detection sensitivity after enrichment by Cas9/sgRNA digestion and PCR amplification.
    Wang L; Jiang J; Li X; Li K; He R; Li J; Duan L; Luo W; Hu Z; Luo D
    Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(12):1316-1324. PubMed ID: 33216845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A profile on cobas® EGFR Mutation Test v2 as companion diagnostic for first-line treatment of patients with non-small cell lung cancer.
    Torres S; González Á; Cunquero Tomas AJ; Calabuig Fariñas S; Ferrero M; Mirda D; Sirera R; Jantus-Lewintre E; Camps C
    Expert Rev Mol Diagn; 2020 Jun; 20(6):575-582. PubMed ID: 32011193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.